{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:31:56Z","timestamp":1780374716850,"version":"3.54.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":666,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RSA 5880014"],"award-info":[{"award-number":["RSA 5880014"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["Government Budget to Chulalongkorn University (Fiscal year 2015)"],"award-info":[{"award-number":["Government Budget to Chulalongkorn University (Fiscal year 2015)"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CUAASC"],"award-info":[{"award-number":["CUAASC"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship"],"award-info":[{"award-number":["The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)"],"award-info":[{"award-number":["The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1074\/mcp.ra118.000735","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T18:16:10Z","timestamp":1533924970000},"page":"2197-2215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comprehensive Proteomics Identification of IFN-\u03bb3-regulated Antiviral Proteins in HBV-transfected Cells"],"prefix":"10.1016","volume":"17","author":[{"given":"Jiradej","family":"Makjaroen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorichaya","family":"Somparn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witthaya","family":"Poomipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattiya","family":"Hirankarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-2271","authenticated-orcid":false,"given":"Trairak","family":"Pisitkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA118.000735_bib1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1074\/mcp.RA118.000735_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Grimm","year":"2011","journal-title":"Hepatol. Int"},{"key":"10.1074\/mcp.RA118.000735_bib3","first-page":"S1","article-title":"Introduction to chronic hepatitis B infection","volume":"101","author":"Wright","year":"2006","journal-title":"Am. J. Gastroenterol"},{"key":"10.1074\/mcp.RA118.000735_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol"},{"key":"10.1074\/mcp.RA118.000735_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2010.06545.x","article-title":"Treatment of chronic hepatitis B: Evolution over two decades","volume":"26","author":"Yuen","year":"2011","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1074\/mcp.RA118.000735_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1756283X08093944","article-title":"Current status of antiviral therapy for Hepatitis B","volume":"1","author":"Lau","year":"2008","journal-title":"Therap. Adv. Gastroenterol"},{"key":"10.1074\/mcp.RA118.000735_bib7","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J. Antimicrobial Chemother"},{"key":"10.1074\/mcp.RA118.000735_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fimmu.2017.00621","article-title":"Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic Hepatitis B patients","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol"},{"key":"10.1074\/mcp.RA118.000735_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2015.12.018","article-title":"Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)","volume":"64","author":"Chan","year":"2016","journal-title":"J. Hepatol"},{"key":"10.1074\/mcp.RA118.000735_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/gene.2008.87","article-title":"Human interferon-lambda3 is a potent member of the type III interferon family","volume":"10","author":"Dellgren","year":"2009","journal-title":"Genes Immunity"},{"key":"10.1074\/mcp.RA118.000735_bib11","article-title":"The interferon receptors","volume":"24","author":"Pestka","year":"1997","journal-title":"Sem. Oncol"},{"key":"10.1074\/mcp.RA118.000735_bib12","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type I Interferon Receptors: Biochemistry and Biological Functions","volume":"282","author":"de Weerd","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA118.000735_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2009.05241.x","article-title":"Interferon lambda as a potential new therapeutic for hepatitis C","volume":"1182","author":"Miller","year":"2009","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/mcp.RA118.000735_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jir.2010.0066","article-title":"Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C","volume":"30","author":"Ramos","year":"2010","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1074\/mcp.RA118.000735_bib15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep.26653","article-title":"Kinetic Differences in the Induction of Interferon Stimulated Genes by Interferon-\u03b1 and IL28B are altered by Infection with Hepatitis C Virus","volume":"59","author":"Jilg","year":"2014","journal-title":"Hepatology"},{"key":"10.1074\/mcp.RA118.000735_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"key":"10.1074\/mcp.RA118.000735_bib17","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons \u03b1 and \u03bb inhibit Hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1074\/mcp.RA118.000735_bib18","doi-asserted-by":"crossref","first-page":"32269","DOI":"10.1074\/jbc.M404789200","article-title":"Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29\/interferon-lambda 1: similarities with type I interferon signaling","volume":"279","author":"Dumoutier","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA118.000735_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1189\/jlb.0204117","article-title":"The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain","volume":"76","author":"Donnelly","year":"2004","journal-title":"J. Leukocyte Biol"},{"key":"10.1074\/mcp.RA118.000735_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA118.000735_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/v8010021","article-title":"Advances and challenges in studying Hepatitis B virus in vitro","volume":"8","author":"Witt-Kehati","year":"2016","journal-title":"Viruses"},{"key":"10.1074\/mcp.RA118.000735_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/v8090261","article-title":"Cell culture models for the investigation of Hepatitis B and D virus infection","volume":"8","author":"Verrier","year":"2016","journal-title":"Viruses"},{"key":"10.1074\/mcp.RA118.000735_bib23","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/pmic.200800621","article-title":"Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2","volume":"9","author":"Wang","year":"2009","journal-title":"Proteomics"},{"key":"10.1074\/mcp.RA118.000735_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0006-291X(02)02861-9","article-title":"Differential cellular gene expression induced by hepatitis B and C viruses","volume":"300","author":"Otsuka","year":"2003","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA118.000735_bib25","first-page":"2178","article-title":"Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell","volume":"55","author":"Xin","year":"2008","journal-title":"Hepato-gastroenterology"},{"key":"10.1074\/mcp.RA118.000735_bib26","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3748\/wjg.v13.i16.2324","article-title":"Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells","volume":"13","author":"Li","year":"2007","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/mcp.RA118.000735_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.tpj.6500459","article-title":"Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs","volume":"8","author":"Ding","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1074\/mcp.RA118.000735_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.4238\/2012.May.18.3","article-title":"Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line","volume":"11","author":"Wang","year":"2012","journal-title":"Gen. Mol. Res"},{"key":"10.1074\/mcp.RA118.000735_bib29","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/pmic.201100335","article-title":"Protein alteration of HepG2.2.15 cells induced by iron overload","volume":"12","author":"Fang","year":"2012","journal-title":"Proteomics"},{"key":"10.1074\/mcp.RA118.000735_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1745-7254.2007.00590.x","article-title":"Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment","volume":"28","author":"Xie","year":"2007","journal-title":"Acta Pharmacol. Sinica"},{"key":"10.1074\/mcp.RA118.000735_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-virology-110615-042238","article-title":"The Structural Biology of Hepatitis B Virus: Form and Function","volume":"3","author":"Venkatakrishnan","year":"2016","journal-title":"Ann. Rev. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/v9030056","article-title":"Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1074\/mcp.RA118.000735_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2014.01.021","article-title":"Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L","volume":"104","author":"Park","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1074\/mcp.RA118.000735_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2016.05.001","article-title":"Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1","volume":"495","author":"Jeong","year":"2016","journal-title":"Virology"},{"key":"10.1074\/mcp.RA118.000735_bib35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bbrc.2014.07.023","article-title":"Inhibition of Hepatitis B virus replication by SAMHD1","volume":"450","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA118.000735_bib36","doi-asserted-by":"crossref","first-page":"26616","DOI":"10.1038\/srep26616","article-title":"Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle","volume":"6","author":"Sommer","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/mcp.RA118.000735_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2015\/959684","article-title":"IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway","volume":"2015","author":"Lu","year":"2015","journal-title":"BioMed Res. Int"},{"key":"10.1074\/mcp.RA118.000735_bib38","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.0308340100","article-title":"Signal transduction pathways that inhibit hepatitis B virus replication","volume":"101","author":"Robek","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA118.000735_bib39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1074\/mcp.RA118.000735_bib40","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of Hepatitis B Virus Infection by Rab5, Rab7, and the Endolysosomal Compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3748\/wjg.v13.i1.39","article-title":"Intracellular transport of hepatitis B virus","volume":"13","author":"Kann","year":"2007","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/mcp.RA118.000735_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-6700-1_4","article-title":"Intracytoplasmic transport of Hepatitis B virus capsids","volume":"1540","author":"Osseman","year":"2017","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/mcp.RA118.000735_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/v9010021","article-title":"Nuclear import of Hepatitis B virus capsids and genome","volume":"9","author":"Gallucci","year":"2017","journal-title":"Viruses"},{"key":"10.1074\/mcp.RA118.000735_bib44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1074\/mcp.RA118.000735_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nature Reviews. Immunology"},{"key":"10.1074\/mcp.RA118.000735_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opinion Virol"},{"key":"10.1074\/mcp.RA118.000735_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000353220","article-title":"Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication","volume":"6","author":"Pei","year":"2014","journal-title":"J. Innate Immunity"},{"key":"10.1074\/mcp.RA118.000735_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1074\/mcp.RA118.000735_bib49","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat. Med"},{"key":"10.1074\/mcp.RA118.000735_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2016.07.008","article-title":"JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses","volume":"133","author":"Fu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1074\/mcp.RA118.000735_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.02.001","article-title":"RNA interference screening of interferon-stimulated genes with antiviral activities against classical swine fever virus using a reporter virus","volume":"128","author":"Wang","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1074\/mcp.RA118.000735_bib52","doi-asserted-by":"crossref","first-page":"39898","DOI":"10.1074\/jbc.M110.130781","article-title":"Structure of human stabilin-1 interacting chitinase-like protein (SI-CLP) reveals a saccharide-binding cleft with lower sugar-binding selectivity","volume":"285","author":"Meng","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA118.000735_bib53","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/gb-2007-8-8-r174","article-title":"The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever","volume":"8","author":"Rubins","year":"2007","journal-title":"Gen. Biol"},{"key":"10.1074\/mcp.RA118.000735_bib54","doi-asserted-by":"crossref","first-page":"e2406","DOI":"10.1371\/journal.pntd.0002406","article-title":"Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia\/Lassa reassortant 29 (ML29), a vaccine candidate","volume":"7","author":"Zapata","year":"2013","journal-title":"PLoS Neglected Tropical Dis"},{"key":"10.1074\/mcp.RA118.000735_bib55","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1128\/JVI.06757-11","article-title":"Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection","volume":"86","author":"Ioannidis","year":"2012","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib56","doi-asserted-by":"crossref","first-page":"e69374","DOI":"10.1371\/journal.pone.0069374","article-title":"A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses","volume":"8","author":"Mitchell","year":"2013","journal-title":"PloS ONE"},{"key":"10.1074\/mcp.RA118.000735_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2015.12.017","article-title":"Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins","volume":"164","author":"Lee","year":"2016","journal-title":"Cell"},{"key":"10.1074\/mcp.RA118.000735_bib58","doi-asserted-by":"crossref","first-page":"e0144409","DOI":"10.1371\/journal.pone.0144409","article-title":"The Activation-Induced Assembly of an RNA\/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells","volume":"10","author":"Whisenant","year":"2015","journal-title":"PloS ONE"},{"key":"10.1074\/mcp.RA118.000735_bib59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virusres.2007.03.006","article-title":"Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells","volume":"126","author":"Hong","year":"2007","journal-title":"Virus Res"},{"key":"10.1074\/mcp.RA118.000735_bib60","doi-asserted-by":"crossref","first-page":"e35902","DOI":"10.1371\/journal.pone.0035902","article-title":"IFN-lambda3 inhibits HIV infection of macrophages through the JAK-STAT pathway","volume":"7","author":"Liu","year":"2012","journal-title":"PloS ONE"},{"key":"10.1074\/mcp.RA118.000735_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jir.2006.26.373","article-title":"IFN-lambda: novel antiviral cytokines","volume":"26","author":"Ank","year":"2006","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1074\/mcp.RA118.000735_bib62","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.2010.0060","article-title":"Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus","volume":"30","author":"Pagliaccetti","year":"2010","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1074\/mcp.RA118.000735_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-Lambda: A New Addition to an Old Family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1074\/mcp.RA118.000735_bib64","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1074\/mcp.RA118.000735_bib65","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib66","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-018-03751-6","article-title":"Massive mining of publicly available RNA-seq data from human and mouse","volume":"9","author":"Lachmann","year":"2018","journal-title":"Nature Communications"},{"key":"10.1074\/mcp.RA118.000735_bib67","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1111\/j.1742-4658.2010.07880.x","article-title":"Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon alpha-induced early antiviral signalling","volume":"277","author":"Maiwald","year":"2010","journal-title":"FEBS J"},{"key":"10.1074\/mcp.RA118.000735_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed data sets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database"},{"key":"10.1074\/mcp.RA118.000735_bib69","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1128\/JVI.76.7.3570-3574.2002","article-title":"Inhibition of hepatitis B virus replication by interferon requires proteasome activity","volume":"76","author":"Robek","year":"2002","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib70","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/elps.201100147","article-title":"Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15","volume":"32","author":"Yao","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1074\/mcp.RA118.000735_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Progress Mol. Biol. Translational Sci"},{"key":"10.1074\/mcp.RA118.000735_bib72","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA118.000735_bib73","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"Yu","year":"2010","journal-title":"J. General Virol"},{"key":"10.1074\/mcp.RA118.000735_bib74","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s13238-010-0141-8","article-title":"Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein","volume":"1","author":"Jiang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1074\/mcp.RA118.000735_bib75","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1128\/JVI.01825-10","article-title":"Hepatitis B Virus Regulatory HBx Protein Binds to Adaptor Protein IPS-1 and Inhibits the Activation of Beta Interferon","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib76","doi-asserted-by":"crossref","first-page":"26150","DOI":"10.1038\/srep26150","article-title":"Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a","volume":"6","author":"Hou","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/mcp.RA118.000735_bib77","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.immuni.2014.05.007","article-title":"Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor","volume":"40","author":"Zhu","year":"2014","journal-title":"Immunity"},{"key":"10.1074\/mcp.RA118.000735_bib78","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"10.1074\/mcp.RA118.000735_bib79","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1128\/JVI.79.5.2780-2787.2005","article-title":"Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest","volume":"79","author":"Kino","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib80","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/JVI.74.4.1736-1741.2000","article-title":"Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1","volume":"74","author":"Aoki","year":"2000","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.pharmtox.40.1.617","article-title":"14-3-3 proteins: structure, function, and regulation","volume":"40","author":"Fu","year":"2000","journal-title":"Ann. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/mcp.RA118.000735_bib82","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.06442-11","article-title":"The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake","volume":"86","author":"Yang","year":"2012","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA118.000735_bib83","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1126\/science.294.5550.2376","article-title":"Calcium signaling by HBx protein in hepatitis B virus DNA replication","volume":"294","author":"Bouchard","year":"2001","journal-title":"Science"},{"key":"10.1074\/mcp.RA118.000735_bib84","first-page":"18","article-title":"Inhibitory effect of cyclosporine A on hepatitis B virus replication in vitro and its possible mechanisms","volume":"4","author":"Xia","year":"2005","journal-title":"Hepatobiliary Pancreatic Dis. Int"},{"key":"10.1074\/mcp.RA118.000735_bib85","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.virol.2004.11.019","article-title":"Calcium ions affect the hepatitis B virus core assembly","volume":"332","author":"Choi","year":"2005","journal-title":"Virology"},{"key":"10.1074\/mcp.RA118.000735_bib86","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1357-2725(97)00153-2","article-title":"Calreticulin","volume":"30","author":"Coppolino","year":"1998","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/mcp.RA118.000735_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.it.2012.08.002","article-title":"Calreticulin in the immune system: ins and outs","volume":"34","author":"Raghavan","year":"2013","journal-title":"Trends Immunol"},{"issue":"Pt 2","key":"10.1074\/mcp.RA118.000735_bib88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3440281","article-title":"Calreticulin: one protein, one gene, many functions","volume":"344","author":"Michalak","year":"1999","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.RA118.000735_bib89","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4049\/jimmunol.1103405","article-title":"Hepatitis B virus-induced calreticulin protein is involved in IFN resistance","volume":"189","author":"Yue","year":"2012","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.RA118.000735_bib90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/cam.5.5.17723","article-title":"Filopodia and adhesion in cancer cell motility","volume":"5","author":"Arjonen","year":"2011","journal-title":"Cell Adhesion Migration"},{"key":"10.1074\/mcp.RA118.000735_bib91","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3748\/wjg.v17.i9.1152","article-title":"Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2","volume":"17","author":"Zhao","year":"2011","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1074\/mcp.RA118.000735_bib92","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/ijms18030586","article-title":"Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42","volume":"18","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/mcp.RA118.000735_bib93","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v8060160","article-title":"Endoplasmic Reticulum: The Favorite Intracellular Niche for Viral Replication and Assembly","volume":"8","author":"Romero-Brey","year":"2016","journal-title":"Viruses"},{"key":"10.1074\/mcp.RA118.000735_bib94","doi-asserted-by":"crossref","first-page":"a013250","DOI":"10.1101\/cshperspect.a013250","article-title":"How Viruses Use the Endoplasmic Reticulum for Entry, Replication, and Assembly","volume":"5","author":"Inoue","year":"2013","journal-title":"Cold Spring Harbor Perspectives Biol"},{"key":"10.1074\/mcp.RA118.000735_bib95","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dna.2016.3611","article-title":"Hypusination of eIF5A as a target for antiviral therapy","volume":"36","author":"Olsen","year":"2017","journal-title":"DNA Cell Biol"},{"key":"10.1074\/mcp.RA118.000735_bib96","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fimmu.2017.01302","article-title":"Identification of a predominantly interferon-lambda-induced transcriptional profile in murine intestinal epithelial cells","volume":"8","author":"Selvakumar","year":"2017","journal-title":"Front. Immunol"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620320235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620320235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA118.000735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:34:05Z","timestamp":1761525245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620320235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1535947620320235"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra118.000735","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Proteomics Identification of IFN-\u03bb3-regulated Antiviral Proteins in HBV-transfected Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA118.000735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Makjaroen et al.","name":"copyright","label":"Copyright"}]}}